Page last updated: 2024-08-21

4-methylcatechol and Fatty Liver, Nonalcoholic

4-methylcatechol has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Choi, HK; Chung, MY; Hwang, JT; Lee, J; Lee, JH; Nam, TG; Park, JH; Song, JH	1

Other Studies

1 other study(ies) available for 4-methylcatechol and Fatty Liver, Nonalcoholic

Article	Year
3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity. Acta pharmacologica Sinica, 2021, Volume: 42, Issue:9 Topics: Animals; Catechols; E1A-Associated p300 Protein; Hep G2 Cells; Histone Acetyltransferases; Histones; Humans; Lipoproteins; Male; Mice; Non-alcoholic Fatty Liver Disease; Rutin; Triglycerides	2021

Article

Year

3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity.

Acta pharmacologica Sinica, 2021, Volume: 42, Issue:9

Topics: Animals; Catechols; E1A-Associated p300 Protein; Hep G2 Cells; Histone Acetyltransferases; Histones; Humans; Lipoproteins; Male; Mice; Non-alcoholic Fatty Liver Disease; Rutin; Triglycerides

2021